Baker Bros. Advisors LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $7.52 Billion distributed in 95 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Incyte Corp with a value of $1.86B, Bei Gene, Ltd. with a value of $1.51B, Acadia Pharmaceuticals Inc with a value of $697M, Madrigal Pharmaceuticals, Inc. with a value of $553M, and Revolution Medicines, Inc. with a value of $294M.
Examining the 13F form we can see an decrease of $373M in the current position value, from $7.9B to 7.52B.
Baker Bros. Advisors LP is based out at New York, NY
Below you can find more details about Baker Bros. Advisors LP portfolio as well as his latest detailed transactions.